Details for Patent: 11,833,286

« Back to Dashboard

Which drugs does patent 11,833,286 protect, and when does it expire?

Patent 11,833,286 protects HEPZATO and is included in one NDA.

This patent has fourteen patent family members in eight countries.

Summary for Patent: 11,833,286

Title:	Filter and frame apparatus and method of use
Abstract:	Provided is a filter apparatus, comprising two or more filter cartridges having a first end with an inlet and screen and a second end with an outlet and screen, and walls to contain a filter media held in a housing for holding the two or more filter cartridges in about the same orientation, and an attachment clamp connected to the housing. Also provided is a housing for holding two or more filter cartridges in about the same orientation and a method of using the filter apparatus and housing.
Inventor(s):	William M. Appling, Stephen N. Engelhard, Matthew G. Barton
Assignee:	Delcath Systems Inc
Application Number:	US17/369,905
Patent Claim Types: see list of patent claims	Compound; Delivery; Device;

Drugs Protected by US Patent 11,833,286

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Delcath Systems Inc	HEPZATO	melphalan hydrochloride	POWDER;INTRA-ARTERIAL	201848-001	Aug 14, 2023		RX	Yes	Yes			Y

International Family Members for US Patent 11,833,286

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Denmark	3603693
European Patent Office	2797644
European Patent Office	3238762
European Patent Office	3360588
European Patent Office	3603693
Spain	2736176